Position in CRMD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$220,660
-$785,334 QoQ
Shares Held
32,498
-62.4% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. CRMD ranks #180 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $220,660 | 32,498 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,005,994 | 86,500 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $545,260 | 46,884 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $427,306 | 34,684 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $191,427 | 31,076 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $246,409 | 30,421 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $155,669 | 19,266 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $84,356 | 19,482 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $76,238 | 17,981 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $59,249 | 15,758 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $43,641 | 11,795 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $78,089 | 19,670 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $31,425 | 7,447 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $21,051 | 7,439 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,728 | 1,425 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $50,097 | 9,142 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $103,242 | 22,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,351 | 721 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,947 | 867 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $115,124 | 11,524 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $266,870 | 35,918 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $160,378 | 26,597 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $202,361 | 32,121 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $146,801 | 40,892 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||